Evaluation of hemangioma by positron emission tomography: Role in a multimodality approach

Journal of Computer Assisted Tomography

Volumn 27, Issue 1, 2003, Pages 70-77

  Hatayama, Kazuhisa ^a   Watanabe, Hideomi ^a   Refaat Ahmed, Adel ^a   Yanagawa, Takashi ^a   Shinozaki, Tetsuya ^a   Oriuchi, Noboru ^a   Aoki, Jun ^a   Takeuchi, Kimihiko ^a   Endo, Keigo ^a   Takagishi, Kenji ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Angiography; CT; Hemangioma; MRI; PET

Indexed keywords

ANGIOGRAPHY; COMPUTERIZED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; POSITRONS; TUMORS;

COMPUTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; FLUORINE-18; FLUORO 2 DEOXY D GLUCOSE; HAEMANGIOMA; IMAGING MODALITY; MULTI-MODALITY; RELATIVE UTILITY; STANDARDIZED UPTAKE VALUES;

MAGNETIC RESONANCE IMAGING;

FLUORODEOXYGLUCOSE F 18; METIROSINE;

ADOLESCENT; ADULT; ANGIOGRAPHY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HEMANGIOMA; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR LOCALIZATION;

EID: 0037254119     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200301000-00013     Document Type: Article

References (23)

1. Enzinger FM, Weiss SW. Benign tumors and tumorlike lesions of blood vessels. In: Enzinger FM, Weiss SW, eds. Soft tissue tumors. 3rd Edition. St. Louis: Mosby, 1995:579-626.
2. Greenspan A, McGahan J, Vogelsang P, et al. Imaging strategies in the evaluation of soft tissue hemangiomas of the extremities: correlation of the findings of plain radiography, angiography, CT, MRI, and ultrasonography in 12 histologically proven cases. Skeletal Radiol 1992;21:11-8.
3. Hawnaur JM, Whitehouse RW, Jenkins JPR, et al. Musculoskeletal haemangiomas: comparison of MRI with CT. Skeletal Radiol 1990;19:251-8.
4. Kern KA, Brunetti A, Norton JA, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 1988;29:181-6.
5. Nieweg OE, Pruim J, Van Genkel RJ, et al. Fluorine-18-fluorideoxyglucose PET imaging of soft tissue sarcoma. J Nucl Med 1996;37:257-61.
6. Adler LP, Blair HF, Makley JT, et al. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 1991;32:1508-12.
7. Kole AC, Plaat BE, Hoekstra HJ, et al. FDG and L-[11-1C]-tyrosine imaging of soft tissue tumors before and after therapy. J Nucl Med 1999;40:381-6.
8. Griffeth LK, Dehdashti F, McGuire AH, et al. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 1992;182:185-94.
9. Watanabe H, Shinozaki T, Yanagawa T, et al. Glucose metabolic analysis of musculoskeletal tumors using fluorine-18-FDG-PET as an aid to preoperative planning. J Bone Joint Surg Br 2000;82: 760-7.
10. Kole AC, Nieweg OE, Hoekstra HJ, et al. Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med 1998;39:810-5.
11. 18F-alpha-methyl tyrosine using a separation and purification system. Nucl Med Commun 1997;18:169-75.
12. Inoue T, Shibasaki T, Oriuchi N, et al. F-18 alpha-methyl tyrosine PET studies in patients with brain tumors. J Nucl Med 1999;40: 399-405.
13. Watanabe H, Inoue T, Shinozaki T, et al. PET imaging of musculoskeletal tumors with F-18 alpha-methyltyrosine: comparison with F-18 fluorodeoxyglucose PET. Eur J Nucl Med 2000;27:1509-17.
14. Ahmed AR, Watanabe H, Aoki J, et al. Schwannoma of the extremities: the role of PET in the preoperative planning. Eur J Nucl Med 2001;28:1541-51.
15. Bradley M, Stewart I, Meterweli C. Diagnosis of the peripheral cavernous haemangioma: comparison of ultrasound, CT and RBC scintigraphy. Clin Radiol 1991;44:343-7.
16. Ito K. A comparative study between magnetic resonance imaging and histologic findings of bone and soft tissue tumors. J Jpn Orthop Assoc 1995;69:899-914.
17. Levine E, Wetzel LH, Neff JR. MR imaging and CT of extrahepatic cavernous hemangiomas. AJR Am J Roentgenol 1986;147:1299-304.
18. Enzinger FM, Weiss SW. Alveolar soft tissue sarcoma. In: Enzinger FM, Weiss SW, eds. Soft tissue tumors. 3rd Edition. St. Louis: Mosby, 1995:1067-74.
19. Kransdorf MJ, Jelinek JS, Moser RP, Jr, et al. Soft-tissue masses: diagnosis using MR imaging. AJR Am J Roentgenol 1989;153:541-7.
20. Crim JR, Seeger LL, Yao L, et al. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 1992;185:581-6.
21. Siegel MJ. Magnetic resonance imaging of musculoskeletal soft tissue masses. Radiol Clin North Am 2001;39:701-20.
22. Levin DC, Gordon DH, McSweeney J. Arteriography of peripheral hemangiomas. Radiology 1976;121:625-30.
23. Griffeth LK, Dehdashti F, McGuire AH, et al. PET evaluation of soft tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 1992;182:185-94.